Axolt Brain Supplement for Memory in Aging
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if the Axolt Brain Supplement can enhance memory and mental well-being in individuals over 55. Participants will take the supplement daily for 45 days, with tests at the start and end to measure any changes. The trial compares the supplement's effects with those of a flavored drink placebo. It suits healthy individuals who live independently and are not currently taking similar supplements. As an unphased trial, this study allows participants to contribute to groundbreaking research on cognitive health.
Do I have to stop taking my current medications for the trial?
The trial requires you to stop taking any dietary supplements with the same active ingredients as Axolt. If you're on medications that interact with Axolt's ingredients, you may also need to stop those. The protocol doesn't specify other medications, so check with the trial team for details.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Axolt Brain Supplement consists of plant-based ingredients and excludes stimulants like caffeine. This composition supports brain health without causing jitters or other side effects often linked to stimulants. Instead, it aims to provide safe and lasting support for the brain.
Although specific safety data for Axolt is not available, plant-based ingredients are generally considered safe and are usually well-tolerated by most people. As a dietary supplement, Axolt has likely met basic safety standards. However, dietary supplements are not regulated as strictly as prescription drugs.
Prospective study participants should consult their healthcare provider to determine if Axolt is suitable for them.12345Why are researchers excited about this trial?
Unlike the standard memory supplements that often rely on herbs or vitamins, Axolt Brain Supplement is unique because it combines a novel blend of natural nootropic compounds specifically designed to enhance memory in aging adults. Most treatments focus on improving cognitive function over a long period, but Axolt aims to deliver noticeable improvements in just 45 days. Researchers are excited about its potential because it offers a convenient, daily drinkable solution that could provide quicker cognitive benefits with an easy-to-adopt delivery method.
What evidence suggests that the Axolt Brain Supplement could be effective for memory in aging?
This trial will compare the Axolt Brain Supplement with a placebo to evaluate its effects on memory in aging. Research shows that the Axolt Brain Supplement is designed to boost brain health and mental performance. Although specific data from human studies on this supplement is limited, it contains ingredients known to support brain function. These ingredients are commonly found in products that aim to improve memory and overall brain health. While solid proof of its effectiveness in humans is still being gathered, the supplement is based on scientific research of its individual ingredients. Early signs suggest it may aid memory and mental well-being in older adults.14678
Who Is on the Research Team?
Judith Klein-Seetharaman, PhD
Principal Investigator
Arizona State University
Are You a Good Fit for This Trial?
This trial is for healthy adults aged 55+ who live independently, have good vision and English fluency, no history of cognitive impairment, a MOCA score ≥ 24, not taking similar supplements or psychoactive medications. Excluded are those with certain medical conditions or on conflicting meds.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants take a dietary supplement or placebo daily for 45 days
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Axolt Brain Supplement
- Bolero - Flavored Drink Placebo
Find a Clinic Near You
Who Is Running the Clinical Trial?
Arizona State University
Lead Sponsor